Fig. 2From: Comparative outcomes in patients receiving pirfenidone or nintedanib for idiopathic pulmonary fibrosisComparison of outcomes in patients newly treated with pirfenidone or nintedanib. a Comparison of overall mortality in patients newly treated with pirfenidone or nintedanib;a b Comparison of acute respiratory-related hospital admissions during the drug-exposure period in patients newly treated with pirfenidone or nintedanib;b c Comparative incidence of discontinuation of pirfenidone or nintedanib treatment.b CI confidence interval, m month, y year. aCumulative mortality was estimated using a cumulative incidence function. bCumulative incidence was estimated using a cumulative incidence function. The coloured areas represent the 95% CIBack to article page